Beiersdorf Venture Capital (BVC) is the corporate venture capital arm of Beiersdorf AG, the Hamburg-based global skincare company behind brands such as Nivea and Eucerin. Founded in 2020, BVC partners with startups at the intersection of life sciences, biotechnology, sustainability, AI, and digital health to drive innovation in skincare. In 2025, Beiersdorf launched its second-generation €100 million ($115M) Skin Care Innovation Fund, with individual investments typically ranging from €0.5M to €5M per deal.
50% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $38.2M (across 5 rounds with reported amounts).
Portfolio
9
Fund Size
$115M
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
Top Co-Investors
Last updated: 20 October 2026